Pediatrix Medical Group Reports Fourth Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/30/2026
- S&P 500, Nasdaq advance as soft inflation tempers Fed rate-hike bets
- Equity positioning stays overweight, but summer extremes have eased: Barclays
- Oil prices rise on stalled US-Iran talks and tight fuel markets
- Micron reports Q4 today: Why Lynx Equity sees massive upside
- Moderna: Citi says oncology optimism is priced in, cuts rating to sell
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- S&P 500 flat as higher bond yields counter tech optimism
- Mattel names Roger Lynch as chairman and CEO, replacing Ynon Kreiz
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
Pediatrix Medical Group (MD) PT Raised to $18 at Mizuho
February 21, 2025 12:35 PM ESTMizuho analyst Ann Hynes raised the price target on Pediatrix Medical Group (NYSE: MD) to $18.00 (from $15.00) while maintaining a Neutral rating.
The analyst comments "After a strong Q4:24, we are raising our price target to $18 from $15, updating our 2025E-2026E adjusted EBITDA estimates... More
